---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-008192"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2023-03-20T23:59:59+00:00"
generated_at: "2026-06-17T22:56:03.395263+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# InspireMD promotes Andrea Tommasoli to COO, effective March 19, 2023

## Summary
- Tommasoli previously served as SVP of Global Sales & Marketing since November 2020.
- New annual base salary of €240,000 (≈ $258,000) plus yearly bonus of 35% of base salary.
- CEO Marvin Slosman cited Tommasoli's role in expanding CGuard EPS in EU and preparing for U.S. approval.
- Tommasoli has prior commercial leadership at Integra LifeSciences and St. Jude Medical (Abbott).
- Employment agreement has indefinite term with six months' notice period for termination.

## SEC filing metadata
- accession: 0001493152-23-008192
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2023-03-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000149315223008192/0001493152-23-008192-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000149315223008192/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-008192
- JSON: https://secwatch.observer/filing/0001493152-23-008192.json
- Plain text: https://secwatch.observer/filing/0001493152-23-008192.txt

## Key facts
- Executive change
  Andrea Tommasoli changed role as Chief Operating Officer at InspireMD, Inc..
  - Action: promoted
  - Role: Chief Operating Officer
  source text: On March 19, 2023, InspireMD, Inc. (the “Company”), announced that its Board of Directors (the “Board”) promoted Andrea Tommasoli to Chief Operating Officer of the Company, effective as of March 19, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1433607/000149315223008192/0001493152-23-008192-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.